Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA okays Vertis' electrical pain relief device:

This article was originally published in Clinica

Executive Summary

Vertis Neuroscience has gained US FDA 510(k) clearance to sell its non-surgical, minimally invasive electrical stimulation therapy to reduce pain and help rehabilitate patients suffering from low back pain. The Seattle, Washington-based firm said its PNT (percutaneous neuromodulation therapy) system can be used on an outpatient basis in the physician's office and is a cost-effective alternative or adjunct to conventional low back pain treatment. The device delivers electrical stimulation directly to the deep tissue surrounding the spine to alleviate persistent pain.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT064516

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel